profile

T2B Monthly

Tomorrow: The Outsider Advantage in Biopharma Comms

Published 26 days ago • 1 min read

Hi!

While our field has its own regulatory, scientific, and stakeholder complexities, many of the judgment calls we face around trust, executive counsel, reputation, and change aren’t unique to biotech. Communicators in other highly scrutinized sectors often navigate similar pressures, often with lessons that translate in useful ways.

Tomorrow’s Comm Convo brings together communications leaders who have worked both inside and outside of biopharma. They’ll share how working in other industries can shape how we approach communications in the life sciences.

Comm Convo: The Outsider Advantage – Cross-Industry Comms Insights

📅 Thursday, March 26th, 12-1 p.m. ET / 9-10 a.m. PT / 4-5 p.m. GMT

T2B Pro & Student members (complimentary): Log in to your account and access your promo code here.
T2B Basic members ($40): Register here.

We’ll explore how to:

  • Apply cross-industry lessons when advising leaders in complex environments
  • Build influence across functions and organizational cultures
  • Strengthen team adaptability while operating within constraints
  • Bring an outside perspective to evolving trust and stakeholder challenges

Featured speakers:

  • Lilian Anekwe, Director of Global Digital Communications, GSK
  • Alexandra Engel, Vice President, Corporate Communications, Axon
  • Jason Kravitz, Head of External Relations, Duke Health
  • Kathleen Noonan, VP, Head of Corporate Communications, ITM (Moderator)

Join us for a practical discussion on how perspectives from outside biotech can strengthen how we advise, influence, and lead.

See you there!

Lynnea

T2B Monthly

What we're hearing from our communicator community

Read more from T2B Monthly

Hi! A quick reminder that tomorrow we’ll hold our Q2 Patient Advocacy & Engagement Roundtable event. This conversation will look at how biopharma communications are actually experienced by patient organizations... where messaging resonates, where it falls short, and what helps build stronger, more trusted relationships over time. Our speakers will share perspectives on what patient advocacy groups need from biopharma communicators, including how trust is built in practice, what makes...

4 days ago • 1 min read

Hi, Our Q1 masterclass explored what it means for biopharma communicators to show up fully as strategic partners, focusing on how we understand the business, structure our work, and make our impact more visible. Andrea Johnston led the session, bringing a builder’s perspective shaped by 30+ years across corporate, agency, and entrepreneurship (including one of the OG firms in our industry, Pure Communications). Here are 10 takeaways that stood out: Understand the economics of your clients' or...

6 days ago • 2 min read

Hi! Patient organizations are the closest link to the communities biopharma aims to serve. They see firsthand how messaging lands, including where it resonates, where it misses, and where it creates unintended friction. Our upcoming Patient Advocacy & Engagement Roundtable event brings together leaders across patient advocacy, healthcare communications, and patient-centered innovation to share how biopharma communications are experienced on the receiving end. What Patient Advocacy...

10 days ago • 1 min read